- ‘Gay Jeans’ that fade into rainbow-colored denim created
- Divided court strikes down big porn award
- Jimmy Carter: Don’t hurt Russian people with sanctions
- Oldest ex-MLB player dies in Cuba, 2 days shy of 103rd birthday
- ‘Top Gun’ for drones: Squadrons of carrier-based killers have Navy’s approval
- Bill Clinton to endorse Charlie Rangel for re-election
- Pfc. Bradley Manning is now Pfc. Chelsea Manning: Court says so
- Secret base U.S. special forces used to train Libyans now under terrorist control: report
- 9th suspect in N.C. kidnapping turns self in to FBI
- L.A. sheriff admits to testing flyover spy program without notifying residents
Latest Pfizer Items
Federal regulators have approved a vaccine for adults age 50 and older to prevent pneumococcal disease, including the most common type of pneumonia.
Last month, Pfizer's cholesterol-fighting drug Lipitor, the world's best-selling medication, saw the expiration of its patent protection, thus opening the market to generic competition. Within just the past two weeks, Pfizer has lost nearly 50 percent of the market to atorvastatin (the generic version of Lipitor), a figure that probably will rise sharply over the next several months. But instead of cheering on the virtuous cycle of innovation, competition and consumer benefits that this represents, policymakers have slammed Pfizer for slashing the price of its own drug to compete with cheaper generics.
Lipitor is so valuable that Pfizer is practically paying people to keep taking its blockbuster cholesterol medicine after generic competition hits the U.S. market this week.
Pfizer is getting creative to preserve Lipitor's billions in sales as the cholesterol drug gets generic competition in the U.S. market.
Federal health scientists say Pfizer's best-selling vaccine, Prevnar 13, is at least as effective as rival Merck's at helping prevent sometimes deadly infections in adults.
Pfizer Inc.'s just-approved Xalkori, the first new medicine in several years for deadly lung cancer, shows the value of a new research standard: precisely targeting rare diseases linked to gene variants.
The Food and Drug Administration has approved a new Pfizer drug for a subset of lung cancer patients with a particular genetic mutation.
Drug maker Pfizer Inc. says it has begun paying victims and their families affected by its fatal 1996 meningitis study in northern Nigeria.
Pfizer Inc. on Wednesday declined to comment on reports it hopes to start marketing an over-the-counter version of its cholesterol drug Lipitor, the world's biggest-selling prescription drug, after the original version loses patent protection in November.